These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20010563)

  • 1. Biotechs get $1 billion windfall in R&D tax credits.
    Thiel K
    Nat Biotechnol; 2009 Dec; 27(12):1066. PubMed ID: 20010563
    [No Abstract]   [Full Text] [Related]  

  • 2. New tax credit program aims to revive ailing biotech research.
    Clin Transl Sci; 2010 Oct; 3(5):200. PubMed ID: 21500422
    [No Abstract]   [Full Text] [Related]  

  • 3. US biotech firms line up for tax credits.
    Ledford H
    Nature; 2010 Jun; 465(7300):854-5. PubMed ID: 20559355
    [No Abstract]   [Full Text] [Related]  

  • 4. Increasing number of companies found ineligible for SBIR funding.
    Bouchie A
    Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384
    [No Abstract]   [Full Text] [Related]  

  • 5. Chasing biotech, state by state--winners and losers.
    Wilan KH
    Nat Biotechnol; 2005 Feb; 23(2):175-9. PubMed ID: 15696143
    [No Abstract]   [Full Text] [Related]  

  • 6. China pushes liver proteomics.
    Jia H; Louët S
    Nat Biotechnol; 2004 Feb; 22(2):136. PubMed ID: 14755276
    [No Abstract]   [Full Text] [Related]  

  • 7. Germany contemplates new biotech tax scheme.
    Mitchell P
    Nat Biotechnol; 2003 Jun; 21(6):587-8. PubMed ID: 12776130
    [No Abstract]   [Full Text] [Related]  

  • 8. Federal stimulus adds momentum to sequencing stampede.
    Fox JL
    Nat Biotechnol; 2009 Dec; 27(12):1061-2. PubMed ID: 20010558
    [No Abstract]   [Full Text] [Related]  

  • 9. Little science, big bucks.
    DeFrancesco L
    Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387
    [No Abstract]   [Full Text] [Related]  

  • 10. Granting you success.
    Beylin D; Chrisman CJ; Weingarten M
    Nat Biotechnol; 2011 Jul; 29(7):567-70. PubMed ID: 21874663
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 12. The YIC factor.
    Nat Biotechnol; 2005 Oct; 23(10):1187. PubMed ID: 16211041
    [No Abstract]   [Full Text] [Related]  

  • 13. Administrative costs for advance payment of health coverage tax credits: an initial analysis.
    Dorn S
    Issue Brief (Commonw Fund); 2007 Mar; 24():1-12. PubMed ID: 17419151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oh no! Not another acronym?
    Wallner PE
    J Am Coll Radiol; 2004 Sep; 1(9):629. PubMed ID: 17411670
    [No Abstract]   [Full Text] [Related]  

  • 15. Germany biotech gets second chance.
    Sheridan C
    Nat Biotechnol; 2003 Dec; 21(12):1414-5. PubMed ID: 14647310
    [No Abstract]   [Full Text] [Related]  

  • 16. Early experiences with federal health insurance tax credits.
    Ix M
    Find Brief; 2007 Sep; 10(7):1-3. PubMed ID: 17896428
    [No Abstract]   [Full Text] [Related]  

  • 17. Tax incentive for Australian research and development.
    Andrew M
    Australas Biotechnol; 1991 Oct; 1(2):87-8. PubMed ID: 1367646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brussels backs nanotech.
    Nat Nanotechnol; 2007 Feb; 2(2):65. PubMed ID: 18654212
    [No Abstract]   [Full Text] [Related]  

  • 19. Ambitious French biotech plan faces EU hurdle.
    Hodgson J
    Nat Biotechnol; 2003 Feb; 21(2):113-4. PubMed ID: 12560821
    [No Abstract]   [Full Text] [Related]  

  • 20. US budget emphasizes bioterrorism countermeasures.
    Fox JL
    Nat Biotechnol; 2004 Mar; 22(3):256-7. PubMed ID: 14990938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.